About the Cancer Registry of Norway

About the Cancer Registry of Norway

Search

The Registries
Research
Screening

Employees
Vacant positions
Media
Strategy
Data and statistics
Cancer in Norway
Publications
Personvern
Key figures on cancer
Cancer types

About the Cancer Registry of Norway

Search

- The Registries
- Research
- Screening

/

Research Sections and researchers Projects Publications Janus Serum Bank

/

Projects AIMS Asbestoscement and cancer risk Completed projects BADDI The impact of obesity and circulating small RNA in the development of endometrial cancer Biobank Biomarkers for HPV-related cancers COVID-19 and cancer in the Nordic countries CT-undersøkelse av barn og risiko for kreft (EPI-CT)Effects of HPV vaccination in Norway Equalscreen EULAT eradicate GBC Can artificial intelligence increase accuracy and effectiveness of breast cancer screening?Prevalence of HPV Research on environmental toxins and cancer Patient reported outcomes after treatment for colorectal cancer – A prospective nationwide study from The Norwegian Colorectal Cancer Registry Physical activity, cardiorespiratory fitness and cancer Gene activity in testicular cancer SElf-SAMpling Brain tumor among children and adolescents Cardiac catheterization of children with congenital heart defects HPV sequencing HPV vaccination and screening among women born 1975-1996 How quickly do breast cancers grow?ImmigrantScreen Innovative commitment to measures against cancer INSPIRE Effectiveness of digital breast tomosynthesis in population breast cancer screening JanusRNA - identification of early cancer biomarkers Can we apply new methods to better follow up HPV-positive women?AI algorithms in BreastScreen Norway Cost and treatment for patients with lung cancer Cancer among Norwegian offshore workers in Norway Cancer risk among agricultural workers Cancer risk among firefighters Women's lifestyle Long-term quality of life after breast cancer treatment Laryngeal papillomatose / Recurrent Respiratory Papillomatosis Drug use and cancer Drugs and prognosis for melanoma Lifestyle changes and future health LTFU miRPOC - biomarkers for early detection of ovarian cancer Environment, occupation and cancer seminar Nikkel, kobolt og luftveiskreft Norwegian Colorectal Cancer Prevention study New cancer treatment and survival OMOP projects Per- og Polyfluoralkyl substances (PFAS)Persontilpasset mammografiscreening i Norge (PERMS-0)Personalised screening Personalizing colorectal cancer screening by lifestyle Regional differences Prescribed drugs and cutaneous melanoma SARS-CoV-2 in cancer patients Stress management after breast cancer Microbiota and lifestyle in Colorectal Cancer Screeing Testikkelkreft og arv Vaccination effect: Genital wart trends in Norway Impact of vitamin D and obesity on bladder cancer; Risk and survival Vitamin D (calcium, albumin and PTH) and cancer prognosis OriOn Joint Action

/

Effects of HPV vaccination in Norway Dissemination Participant information Meet the research group Financing Background and aim Effects of HPV-vaccination in Norway

Financing

Institute text

Financing

The study is financed by and performed in collaboration with Merck & Co, Inc.

Merck & Co, Inc

Cancer Registry of Norway

Contact information

Telephone switchboard
22 45 13 00
Mon-fri. 09.00-14.30

Read more

Information about the Cancer Registry of Norway
Employees
Vacancies
Contact
Press

Information

The Cancer Registry of Norway is a part of

VAT number 983 744 516

The Cancer Registry of Norway uses cookies
Privacy statement
Avaliaibility statement